EPA should revoke Monsanto weed killer approval, groups tell U.S. court

Image
Reuters
Last Updated : Aug 30 2018 | 1:30 AM IST

By Tina Bellon

(Reuters) - Environmental groups argued in federal appeals court on Wednesday the U.S. Environmental Protection Agency failed to analyse the risks Bayer AG Monsanto's dicamba-based weed killer posed to nearby crops before approving it in 2016.

The groups, which filed a lawsuit in February, want the court to force the EPA to vacate its approval of XtendiMax, arguing it not only harms nearby crops and plants but wildlife as well. It is not clear whether the court has the authority to revoke an EPA approval.

The United States has faced a weed-killer crisis caused by the new formulations of dicamba-based herbicides, which farmers and weed experts say have harmed crops because they evaporate and drift away from where they are applied.

"The EPA's declaration that XtendiMax would have no effect on plants and animals was arbitrary and capricious," Paul Achitoff, a lawyer for non-profit Earthjustice told a three-judge panel at the 9th U.S. Circuit Court of Appeals in Seattle during a hearing.

The arguments come at a critical time for Monsanto and other agrochemical companies that developed dicamba-based products, such as BASF SE's Engenia and DowDuPont Inc's FeXapan. The EPA is currently deciding whether to renew dicamba's sales license, which expires on Nov. 8, for the next growing season.

Monsanto, a unit of Bayer, urged the court to dismiss the lawsuit.

Dicamba is used in part to destroy weeds that have become resistant to glyphosate, another herbicide developed by Monsanto. Monsanto denies crop damage was caused by XtendiMax and says drift occurred because farmers illegally applied older dicamba formulations or failed to follow instructions.

Bayer Chief Executive Werner Baumann during an analyst call last week said his company was in discussions with the EPA about the sales license renewal and expects the agency to decide by October.

Environmental groups, including the National Family Farm Coalition, Center for Food Safety, Center for Biological Diversity and Pesticide Action Network North America, say the EPA failed to conduct its own analysis and instead relied on statements by Monsanto executives and lawyers.

The EPA in 2016 approved new XtendiMax uses for soybean and cotton fields, concluding dicamba would have "no effect" on animals or their habitat.

But U.S. Appeals Court Judge William Fletcher questioned whether the EPA indeed relied on sufficient studies to make its decision.

"After all, you guys turned out to be wrong," Fletcher said, referring to the more than 3 million acres, or 4 percent of the U.S. soybean crop, that was destroyed by dicamba drift during the 2017 planting season, according to a university study.

(Reporting by Tina Bellon in New York; Editing by Lisa Shumaker)

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 30 2018 | 1:16 AM IST

Next Story